title: Prevalence of hyperlipidemia in a cohort of CAPD patients. Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG).
abstract: An association between hyperlipidemia and cardiovascular disease is well described in the literature. We conducted an observational study in order to evaluate the lipid profile, the prevalence of hyperlipidemia and its relationship with age, sex, duration of CAPD, peritoneal glucose load (PGL), serum albumin (ALB), serum glucose (GLU), and BMI in a large cohort of uremics undergoing long-term treatment with CAPD. 457 nondiabetic patients (245 males, 212 females; mean age 63.8 +/- 11.9 years; mean duration of CAPD: 41.8 +/- 26.9 months) treated during 1992 in 25 centers participating in the Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG) were studied. The serum lipid parameters evaluated were triglycerides (TG), total cholesterol (CHO), HDL-cholesterol (HDL). Indications given in the New England Journal of Medicine, SI Unit Conversion Guide, 1992, were adopted for normal ranges. In the whole population the evaluation of lipid parameters showed: TG 227.4 +/- 123.3 mg/dl, CHO 232.8 +/- 56.0 mg/dl, HDL 40.7 +/- 12.0 mg/dl. No differences were found between the two sexes with regard to age, BMI, duration of CAPD, distribution of renal diseases, TG, ALB, and GLU; whereas CHO and HDL were significantly lower in males than in females (CHO: 222.2 +/- 53.5 vs. 245.0 +/- 56.5 mg/dl, p < 0.001; HDL: 39.3 +/- 11.4 vs. 42.6 +/- 12.6 mg/dl, p < 0.05). The prevalence of hypercholesterolemia was significantly lower in males than in females (19.7 vs. 35.4%; p < 0.001). The multiple regression analysis indicated that TG were directly correlated to PGL (p < 0.05), and HDL was inversely correlated with TG (p < 0.001). The coexistence of the two variables (TG and HDL) may increase the risk of cardiovascular events. Further strategies should therefore be developed to select and manage CAPD patients to reduce the incidence of hyperlipidemia.
authors.affiliation: Department of Nephrology, S. Maria delle Croci Hospital, Ravenna, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Cocchi
authors.forename: G
authors.initials: G
authors.lastname: Viglino
authors.forename: G
authors.initials: G
authors.lastname: Cancarini
authors.forename: L
authors.initials: L
authors.lastname: Catizone
authors.forename: A
authors.initials: A
authors.lastname: Favazza
authors.forename: A
authors.initials: A
authors.lastname: Tommasi
authors.forename: M
authors.initials: M
authors.lastname: Salomone
authors.forename: G P
authors.initials: GP
authors.lastname: Segoloni
authors.forename: R
authors.initials: R
authors.lastname: Torpia
authors.forename: A
authors.initials: A
authors.lastname: Giangrande
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000453:epidemiology*; D006949:Hyperlipidemias / Q000097:blood / Q000453:epidemiology*; D007674:Kidney Diseases / Q000097:blood / Q000628:therapy; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D015995:Prevalence; D012016:Reference Values; D012044:Regression Analysis; D012709:Serum Albumin / Q000032:analysis; D012727:Sex Characteristics; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D008075:Lipoproteins, HDL; D012709:Serum Albumin; D014280:Triglycerides; D002784:Cholesterol